GMR Solutions GMRS

NYSE GMRS

$10.76 +0.03 (+0.28%)

As of: Oct 26, 2026 · 2:57 PM EDT

GMR Solutions (GMRS) stock price is $10.76, up 0.28% on the day, as of Oct 26, 2026. It is classified in the Healthcare Services industry (Healthcare sector).

Key Stats

Add ratio to table…

About

GMR, Inc. is the largest provider of emergency medical services and one of the largest integrated providers of essential alternate site out of hospital care in the United States. The company operates a combined air and ground ambulance network that responds to emergency and non emergency calls, providing on-site care and patient transport to appropriate medical facilities. It serves over 1,400 U. S. counties, covering regions that represent more than 60% of the U. S.…

GMR, Inc. generates revenue primarily through fee for service payments for emergency medical transports, which account for about 90% of its total revenue. Additional revenue comes from contracted services with health systems, government agencies, and private payors for both emergent and nonemergent care, including subscription membership programs and specialized transport solutions. The company’s revenue is diversified across more than 650 commercial payors and 600 operating locations, reducing reliance on any single source.

The company operates through the following segments.

Emergent Care: This segment provides emergency medical services, responding to 911 calls with ground and air ambulances, delivering life support interventions and transporting patients to appropriate facilities when needed.
Nonemergent Care: This segment offers scheduled nonemergency patient transfers, including hospital discharges, interfacility transfers, and long distance repatriations using ground and air assets.

GMR, Inc. holds a leading position as the nation’s largest emergency medical services provider, operating the only fully integrated national air and ground network. Its main competitors include Air Methods, Metro Aviation, PHI Air Medical, Life Flight Network in the air ambulance space and Falck, Priority Ambulance, and Acadian Ambulance Service in the ground ambulance market. The company’s competitive advantages stem from its extensive scale of over 7,400 ground vehicles and 513 aircraft, its proprietary technology platforms such as Transport. Net and RapidCall, and its evidence based clinical guidelines developed with hundreds of physician partners.

GMR, Inc. serves a broad customer base that includes individual patients, hospitals, health systems, municipalities, and federal and state agencies. Notable customers include the U. S. Department of Homeland Security through FEMA and Imperial County, California, for which the company provides dedicated emergency services. The company also contracts with numerous commercial payors and works with over 700 payers annually to deliver its services.

Investment Thesis

▲ Bull case

GMR Solutions Inc. demonstrates significant margin expansion potential despite modest revenue growth, as evidenced by Q1 2026 results where net income surged 179.7% year-over-year while net revenue grew only 6.6%, indicating powerful operating leverage that the market may be undervaluing given the company's fixed-cost structure in EMS operations. This discrepancy reveals that incremental revenue flows disproportionately to the bottom line due to high fixed costs in labor, fleet maintenance, and infrastructure, suggesting that even modest same-market revenue growth of 7.9% in Q1 2026 could drive substantially higher profitability as the company scales its integrated air and ground network across 1,400 counties serving over 60% of the U.S. population. The market appears to be focusing solely on topline growth metrics without recognizing how GMR's scale advantages in purchasing, centralized dispatch, and cross-utilization of assets create a structural tailwind for margin improvement that is not yet reflected in consensus estimates, particularly as the company benefits from its post-IPO deleveraging trajectory following the $5.4 billion refinancing in 2025. The company's strategic shift toward higher-acuity services presents an underappreciated catalyst for revenue quality improvement, highlighted by the 46.6% year-over-year increase in Nurse Navigation encounters to 28,122 in Q1 2026 alongside declining non-emergent transports (-7.2%) and stable emergent transports, indicating a successful migration toward value-based care models that command higher reimbursement rates and reduce costly emergency department admissions. This shift is further supported by the rising net transport revenue per ambulance transport, which increased 7.9% to $1,360 in Q1 2026, driven by a favorable payor mix shift where commercial insurance and managed care grew to 57% of net transport revenue while Medicare decreased to 25%, demonstrating pricing power in higher-margin commercial contracts that the market overlooks when evaluating topline growth alone. GMR's integrated air-ground capabilities uniquely position it to capture this shift, as air medical services often serve as the gateway to higher-acuity, higher-reimbursement interventions that ground-only competitors cannot replicate. GMR's capital allocation discipline reveals a hidden strength in free cash flow generation that is masked by elevated net capital expenditures, as Q1 2026 showed $54,011,000 in net cash capital expenditures and $24,992,000 in aircraft financing cash usage, yet the company generated $128,743,000 in operating cash flow, resulting in strong free cash flow conversion that supports its deleveraging agenda post-IPO. The market may be misinterpreting the increase in capex as aggressive spending rather than recognizing it as necessary maintenance and fleet modernization to sustain service quality across its extensive 1,400-county footprint, particularly given that weather cancellation rates for emergent air transports improved to 17.1% from 17.9% year-over-year, indicating improving operational reliability from these investments. With the IPO proceeds expected to reduce debt burdens and the company guiding full-year 2026 cash used for net capital expenditures and aircraft financing as only 5.1%-5.3% of net revenue, GMR is positioned to convert its scale into sustainable free cash flow that could support dividend initiation or accelerated debt paydown, creating shareholder value not yet priced into the stock following its recent valuation reset to $3.3 billion.

GMR Solutions Inc. demonstrates significant margin expansion potential despite modest revenue growth, as evidenced by Q1 2026 results where net income surged 179.7% year-over-year while net revenue grew only 6.6%, indicating powerful operating leverage that the market may be undervaluing given the company's fixed-cost structure in EMS operations. This discrepancy reveals that incremental revenue flows disproportionately to the bottom line due to high fixed costs in labor, fleet maintenance, and infrastructure, suggesting that even modest same-market revenue growth of 7.9% in Q1 2026 could drive substantially higher profitability as the company scales its integrated air and ground network across 1,400 counties serving over 60% of the U.S. population. The market appears to be focusing solely on topline growth metrics without recognizing how GMR's scale advantages in purchasing, centralized dispatch, and cross-utilization of assets create a structural tailwind for margin improvement that is not yet reflected in consensus estimates, particularly as the company benefits from its post-IPO deleveraging trajectory following the $5.4 billion refinancing in 2025. The company's strategic shift toward higher-acuity services presents an underappreciated catalyst for revenue quality improvement, highlighted by the 46.6% year-over-year increase in Nurse Navigation encounters to 28,122 in Q1 2026 alongside declining non-emergent transports (-7.2%) and stable emergent transports, indicating a successful migration toward value-based care models that command higher reimbursement rates and reduce costly emergency department admissions. This shift is further supported by the rising net transport revenue per ambulance transport, which increased 7.9% to $1,360 in Q1 2026, driven by a favorable payor mix shift where commercial insurance and managed care grew to 57% of net transport revenue while Medicare decreased to 25%, demonstrating pricing power in higher-margin commercial contracts that the market overlooks when evaluating topline growth alone. GMR's integrated air-ground capabilities uniquely position it to capture this shift, as air medical services often serve as the gateway to higher-acuity, higher-reimbursement interventions that ground-only competitors cannot replicate. GMR's capital allocation discipline reveals a hidden strength in free cash flow generation that is masked by elevated net capital expenditures, as Q1 2026 showed $54,011,000 in net cash capital expenditures and $24,992,000 in aircraft financing cash usage, yet the company generated $128,743,000 in operating cash flow, resulting in strong free cash flow conversion that supports its deleveraging agenda post-IPO. The market may be misinterpreting the increase in capex as aggressive spending rather than recognizing it as necessary maintenance and fleet modernization to sustain service quality across its extensive 1,400-county footprint, particularly given that weather cancellation rates for emergent air transports improved to 17.1% from 17.9% year-over-year, indicating improving operational reliability from these investments. With the IPO proceeds expected to reduce debt burdens and the company guiding full-year 2026 cash used for net capital expenditures and aircraft financing as only 5.1%-5.3% of net revenue, GMR is positioned to convert its scale into sustainable free cash flow that could support dividend initiation or accelerated debt paydown, creating shareholder value not yet priced into the stock following its recent valuation reset to $3.3 billion.

▼ Bear case

GMR Solutions Inc. faces significant margin pressure from persistent labor cost inflation that management inadequately addressed in its commentary, as employee wages, benefits, and taxes rose 4.8% year-over-year to $770,006,000 in Q1 2026 while net revenue grew only 6.6%, revealing that labor costs are consuming nearly all incremental revenue growth despite the company's claims of executing its strategy with discipline. This trend is particularly concerning given that labor represents over 50% of total operating expenses and the company operates in a highly unionized industry where wage pressures are structural rather than transient, yet management highlighted only top-line and net income growth without acknowledging the unsustainable trajectory of wage growth outpacing inflation in key markets, suggesting that future margin expansion will be constrained by unavoidable collective bargaining agreements and competitive bidding for scarce EMT and paramedic talent across its 1,400-county footprint. The company's reliance on non-recurring adjustments to bolster Adjusted EBITDA presents a material risk to earnings quality that is not sufficiently transparent, as professional fees and other expenses for non-recurring matters increased 51.8% year-over-year to $6,911,000 in Q1 2026, representing over 2.2% of net revenue and driven significantly by $3,296,000 in categorized "Other" expenses with unclear nature, while management framed these as isolated items despite their consistent quarterly appearance and growing magnitude. This pattern raises concerns about the sustainability of the reported 9.7% Adjusted EBITDA growth, especially when combined with the $5,674,000 realized and unrealized gain on marketable securities that inflated EBITDA—a non-operating item unlikely to recur at similar levels—yet the guidance for full-year 2026 Adjusted EBITDA ($1,135-$1,195 million) implies continued reliance on such adjustments to meet targets, potentially misleading investors about the true operating profitability of GMR's core EMS operations in an industry facing reimbursement pressure from Medicare Advantage plans and Medicaid rate freezes. GMR's balance sheet vulnerability to interest rate fluctuations creates a material downside risk that is underemphasized in its forward-looking statements, as long-term debt remained elevated at $4,894,435,000 as of March 31, 2026, with accrued interest rising 21.0% to $91,504,000 year-over-year despite modest debt reduction, and the company's interest expense, net, while down 26.8% year-over-year due to prior-period paid-in-kind interest, remains structurally high given its $5.4 billion 2025 refinancing at elevated rates during a period of monetary tightening. The market may be overlooking how even modest increases in benchmark rates could significantly impact debt service costs, especially given that the company's cash used for net capital expenditures and aircraft financing is guided at 5.1%-5.3% of net revenue for full-year 2026, leaving limited cushion for interest rate shocks, and with $208,947,000 in deferred income tax liabilities and $310,619,000 in insurance reserves, GMR has minimal liquidity buffer beyond its $426,092,000 in cash and cash equivalents to absorb a simultaneous rise in borrowing costs and potential deterioration in receivables collection during economic slowdowns that could disproportionately affect its self-pay and Medicaid populations.

GMR Solutions Inc. faces significant margin pressure from persistent labor cost inflation that management inadequately addressed in its commentary, as employee wages, benefits, and taxes rose 4.8% year-over-year to $770,006,000 in Q1 2026 while net revenue grew only 6.6%, revealing that labor costs are consuming nearly all incremental revenue growth despite the company's claims of executing its strategy with discipline. This trend is particularly concerning given that labor represents over 50% of total operating expenses and the company operates in a highly unionized industry where wage pressures are structural rather than transient, yet management highlighted only top-line and net income growth without acknowledging the unsustainable trajectory of wage growth outpacing inflation in key markets, suggesting that future margin expansion will be constrained by unavoidable collective bargaining agreements and competitive bidding for scarce EMT and paramedic talent across its 1,400-county footprint. The company's reliance on non-recurring adjustments to bolster Adjusted EBITDA presents a material risk to earnings quality that is not sufficiently transparent, as professional fees and other expenses for non-recurring matters increased 51.8% year-over-year to $6,911,000 in Q1 2026, representing over 2.2% of net revenue and driven significantly by $3,296,000 in categorized "Other" expenses with unclear nature, while management framed these as isolated items despite their consistent quarterly appearance and growing magnitude. This pattern raises concerns about the sustainability of the reported 9.7% Adjusted EBITDA growth, especially when combined with the $5,674,000 realized and unrealized gain on marketable securities that inflated EBITDA—a non-operating item unlikely to recur at similar levels—yet the guidance for full-year 2026 Adjusted EBITDA ($1,135-$1,195 million) implies continued reliance on such adjustments to meet targets, potentially misleading investors about the true operating profitability of GMR's core EMS operations in an industry facing reimbursement pressure from Medicare Advantage plans and Medicaid rate freezes. GMR's balance sheet vulnerability to interest rate fluctuations creates a material downside risk that is underemphasized in its forward-looking statements, as long-term debt remained elevated at $4,894,435,000 as of March 31, 2026, with accrued interest rising 21.0% to $91,504,000 year-over-year despite modest debt reduction, and the company's interest expense, net, while down 26.8% year-over-year due to prior-period paid-in-kind interest, remains structurally high given its $5.4 billion 2025 refinancing at elevated rates during a period of monetary tightening. The market may be overlooking how even modest increases in benchmark rates could significantly impact debt service costs, especially given that the company's cash used for net capital expenditures and aircraft financing is guided at 5.1%-5.3% of net revenue for full-year 2026, leaving limited cushion for interest rate shocks, and with $208,947,000 in deferred income tax liabilities and $310,619,000 in insurance reserves, GMR has minimal liquidity buffer beyond its $426,092,000 in cash and cash equivalents to absorb a simultaneous rise in borrowing costs and potential deterioration in receivables collection during economic slowdowns that could disproportionately affect its self-pay and Medicaid populations.

Peer group

Peer Comparison

Companies in the Healthcare Services

View all peers

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	HCA	HCA Healthcare, Inc.	102.07 Bn	14.92	1.31	49.72 Bn
2	NTRA	Natera, Inc.	57.46 Bn	-298.64	21.22	0.08 Bn
3	LH	Labcorp Holdings Inc.	26.75 Bn	26.68	1.86	5.86 Bn
4	DGX	Quest Diagnostics Inc	26.59 Bn	23.55	2.25	5.55 Bn
5	GH	Guardant Health, Inc.	22.86 Bn	-50.41	19.32	-
6	THC	Tenet Healthcare Corp	22.44 Bn	10.01	1.03	13.25 Bn
7	FMS	Fresenius Medical Care AG	13.25 Bn	12.12	1.20	541.49 Bn
8	EHC	Encompass Health Corp	12.25 Bn	19.73	1.97	2.63 Bn

GMR Solutions GMRS

About

Investment Thesis

Peer Comparison

Create an account

Sign In

Reset Password